DLD Asset Management »

Xenon Pharmaceuticals shares owned by DLD Asset Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $209k 5.2k 40.14

More positions owned by DLD Asset Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Centrus Energy Corp Cl A Put Option (LEU)
Echostar Corp Note 3.875%11/3 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Ishares Tr Ishares Biotech Put Option (IBB)
Spirit Aerosystems Note 3.250%11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Bristol Myers Squibb (BMY)

View all positions for DLD Asset Management

Top funds holding Xenon Pharmaceuticals

FMR
venBio Select Advisor
BlackRock
Driehaus Capital Management
Henderson Group
Wellington Management Company
Braidwell
Capital Research and Management Company - Division 3
Commodore Capital
Polar Capital Holdings
Holocene Advisors
Alliancebernstein
State Street Corporation
Millennium Management
Affinity Asset Advisors

View all funds holding Xenon Pharmaceuticals